Upgrade to SI Premium - Free Trial

RXO, Inc. (RXO) PT Raised to $20 at Goldman Sachs

July 16, 2026 6:36 AM
Goldman Sachs analyst Jordan Alliger raised the price target on RXO, Inc. (NYSE: RXO) to $20.00 (from $18.00) while maintaining a Neutral rating.

Categories

Analyst PT Change